Gland Pharma shares jump 4% as Q2 profit climbs 58%, revenue rises 23% YoY

Revenue rose 23% year on year to Rs 18.34 billion. Adjusted EBITDA increased 50%. The stock hit a 52-week high of Rs 3,345.